Adjuvant bleomycin, etoposide and cisplatin in pathological stage II non-seminomatous testicular cancer - the Indiana University experience

By Behnia M.   Foster R.   Einhorn L.H.   Donohue J.   Nichols C.R.  

European Journal of Cancer, Vol. 36, Iss. 4, 2000-03 ,pp. : 472-475

Elsevier

Access to resources Recommend Favorite

Clinical Stage B Non-seminomatous Germ Cell Testis Cancer: The Indiana University Experience (1965-1989) Using Routine Primary Retroperitoneal Lymph Node Dissection

By Donohue J.P.   Thornhill J.A.   Foster R.S.   Rowland R.G.   Bihrle R.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1599-1604

Elsevier

Access to resources Recommend Favorite

Changes in the Incidence and Mortality of Testicular Cancer in Scotland with Particular Reference to the Outcome of Older Patients Treated for Non-seminomatous Germ Cell Tumours

By Hatton M.Q.F.   Paul J.   Harding M.   MacFarlane G.   Robertson A.G.   Kaye S.B.  

European Journal of Cancer, Vol. 31, Iss. 9, 1995-09 ,pp. : 1487-1491

Elsevier

Access to resources Recommend Favorite

High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer – a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)

By Haugnes Hege S.   Laurell Anna   Stierner Ulrika   Bremnes Roy M.   Dahl Olav   Cavallin-Ståhl Eva   Cohn-Cedermark Gabriella  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 168-176

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Significance of Marker Half-life during Chemotherapy in Non-seminomatous Germ Cell Testicular Tumors

By İnanç Sevil E.   Meral Rasim   Darendeliler Emin   Yasasever Vildan   Onat Haluk  

Acta Oncologica, Vol. 38, Iss. 4, 1999-05 ,pp. : 505-509

Informa Healthcare

Access to resources Recommend Favorite